BHC
$9.25
2.436%

Bausch Health Companies Inc.
News & Events

Last updated: Jul 24, 2025, 11:35 PM ET

  1. Bausch Health Announces the Appointment of Two New Members to Its Board of Directors

    ACCESS Newswire JUL 24, 2025 8:02 AM EDT
    LAVAL, QC / ACCESS Newswire / July 24, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...
    READ ARTICLE
  2. CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs

    ACCESS Newswire JUL 10, 2025 5:00 PM EDT
    This press release updates the headline of the previously posted release LAVAL, QC / ACCESS...
    READ ARTICLE
  3. Bausch Health Appoints New Chief Accounting Officer

    ACCESS Newswire JUL 10, 2025 4:15 PM EDT
    LAVAL, QC / ACCESS Newswire / July 10, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC)...
    READ ARTICLE
  4. Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs

    ACCESS Newswire JUL 9, 2025 8:00 AM EDT
    LAVAL, QC / ACCESS Newswire / July 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health...
    READ ARTICLE
  5. Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence

    ACCESS Newswire JUL 7, 2025 8:00 AM EDT
    Focused on highlighting real patient experiences, Salix continues to lead the charge in educating...
    READ ARTICLE
  6. Bausch Health to Announce Second Quarter 2025 Results on July 30

    ACCESS Newswire JUL 2, 2025 7:00 AM EDT
    LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ...
    READ ARTICLE
  7. Bausch Health Announces 2025 Annual Meeting of Shareholder Results

    ACCESS Newswire MAY 14, 2025 4:15 PM EDT
    LAVAL, QC / ACCESS Newswire / May 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ...
    READ ARTICLE
  8. Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization

    ACCESS Newswire MAY 6, 2025 8:00 AM EDT
    New analysis suggests efficacy of Xifaxan to mitigate OHE rehospitalizations irrespective of trea...
    READ ARTICLE
  9. Bausch Health Announces First Quarter 2025 Results

    ACCESS Newswire APR 30, 2025 4:05 PM EDT
    First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Orga...
    READ ARTICLE
  10. Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System

    ACCESS Newswire APR 29, 2025 8:00 AM EDT
    A Long-Awaited Advancement in Non-Invasive Radiofrequency Skin Tightening Is Now Approved for the...
    READ ARTICLE

Upcoming Events

Get notified of Bausch Health Companies Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement

    Not Available
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available